Skip to main content
. Author manuscript; available in PMC: 2014 Nov 4.
Published in final edited form as: Mol Pharm. 2013 Oct 21;10(11):4099–4106. doi: 10.1021/mp4005468

Figure 4.

Figure 4

Evaluation of nanovector toxicity. (a) Alamar blue cell viability assay (viability was normalized to untreated cells). TEM investigation of nanovector treatment effects on C6/GFP+ on plasma membrane structures (b), and mitochondrial membranes (c). The scale bars correspond to 100 nm.